{Reference Type}: Clinical Trial, Phase II
{Title}: Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults.
{Author}: Oh I;Hatano K;Ikeda T;Toda Y;Minakata D;Kawaguchi S;Morita K;Yamamoto C;Ashizawa M;Sato K;Kameda K;Gomyo A;Misaki Y;Kawamura S;Kimura S;Kobayashi H;Sato H;Nakasone H;Ohmine K;Fujiwara S;Kako S;Kanda Y;
{Journal}: Leuk Res
{Volume}: 137
{Issue}: 0
{Year}: 2024 02 17
{Factor}: 3.715
{DOI}: 10.1016/j.leukres.2024.107438